What Sectoral Asset Management Inc reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1274413 · Filed Aug 14, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 430.4K |
| ±0% |
| $8.7M |
| 6.1% |
LLYELI LILLY & Co | 6.4K | ±0% | $7.6M | 5.3% |
UNHUnitedHealth Group Inc | 13.2K | −11.5% | $5.5M | 3.8% |
JNJJohnson & Johnson | 18.2K | ±0% | $4.6M | 3.2% |
ORKAOruka Therapeutics, Inc. | 42K | New | $4M | 2.8% |
BNTXBioNTech SE | 41.9K | +88.9% | $3.9M | 2.7% |
DFTXDefinium Therapeutics, Inc. | 78.3K | New | $3.7M | 2.6% |
DXCMDexCom Inc | 50.8K | +118.5% | $3.4M | 2.4% |
RCUSArcus Biosciences, Inc. | 110.9K | +146.0% | $3.4M | 2.4% |
AMGNAmgen Inc | 9.2K | ±0% | $3.3M | 2.3% |
SMMTSummit Therapeutics Inc. | 220.2K | +216.3% | $3.2M | 2.2% |
IRTCiRhythm Holdings, Inc. | 26.1K | New | $3.1M | 2.2% |
ABBVAbbVie Inc. | 12.2K | ±0% | $3.1M | 2.1% |
MRKMerck & Co., Inc. | 21.5K | ±0% | $2.8M | 1.9% |
AVBPArriVent BioPharma, Inc. | 79K | +163.4% | $2.7M | 1.9% |
VRTXVertex Pharmaceuticals Inc | 5.4K | −22.5% | $2.7M | 1.9% |
ARGXArgenx SE | 2.8K | −20.6% | $2.6M | 1.8% |
GILDGilead Sciences, Inc. | 20.6K | −25.0% | $2.6M | 1.8% |
INSMINSMED Inc | 23.2K | +18.0% | $2.5M | 1.7% |
TECXTectonic Therapeutic, Inc. | 71K | +272.6% | $2.4M | 1.7% |
ISRGIntuitive Surgical Inc | 5.9K | +11.4% | $2.3M | 1.6% |
IMTXImmatics N.V. | 224.9K | +236.6% | $2.3M | 1.6% |
SYKStryker Corp | 7.1K | +21.4% | $2.2M | 1.6% |
AVTXAvalo Therapeutics, Inc. | 119.9K | New | $2.2M | 1.5% |
CBIOCrescent Biopharma, Inc. | 121.3K | New | $2.2M | 1.5% |
ROIVRoivant Sciences Ltd. | 61.1K | +88.0% | $2.2M | 1.5% |
IQVIQVIA Holdings Inc. | 10.8K | +30.6% | $2.1M | 1.5% |
PLSEPulse Biosciences, Inc. | 67.9K | New | $1.9M | 1.3% |
DHRDanaher Corp | 9.6K | ±0% | $1.8M | 1.3% |
TMOThermo Fisher Scientific Inc. | 3.5K | ±0% | $1.8M | 1.2% |
ABTAbbott Laboratories | 18.1K | −29.3% | $1.6M | 1.1% |
ATECAlphatec Holdings, Inc. | 185.9K | New | $1.6M | 1.1% |
BSXBoston Scientific Corp | 36.3K | +4.5% | $1.6M | 1.1% |
TMDXTransMedics Group, Inc. | 22K | New | $1.5M | 1% |
CYTKCytokinetics Inc | 16.3K | +123.7% | $1.4M | 1% |
REGNRegeneron Pharmaceuticals, Inc. | 2.2K | −25.7% | $1.4M | 0.9% |
CVSCVS HEALTH Corp | 13K | New | $1.3M | 0.9% |
EWEdwards Lifesciences Corp | 14.8K | −14.5% | $1.3M | 0.9% |
TRVITrevi Therapeutics, Inc. | 65.6K | −11.9% | $1.2M | 0.9% |
BMYBristol Myers Squibb Co | 21.2K | ±0% | $1.2M | 0.9% |
VERAVera Therapeutics, Inc. | 25.6K | ±0% | $1.1M | 0.8% |
COGTCogent Biosciences, Inc. | 26.7K | +20.8% | $1M | 0.7% |
MDTMedtronic plc | 11.1K | ±0% | $876.3K | 0.6% |
TARSTarsus Pharmaceuticals, Inc. | 13.3K | +17.9% | $836.2K | 0.6% |
KURAKura Oncology, Inc. | 71.5K | ±0% | $784.1K | 0.5% |
CNCCentene Corp | 12K | New | $770.3K | 0.5% |
UTHRUNITED THERAPEUTICS Corp | 1.4K | −19.9% | $742.3K | 0.5% |
HNGEHinge Health, Inc. | 8.7K | −28.6% | $725.8K | 0.5% |
NKTRNektar Therapeutics | 10.1K | −6.8% | $705.8K | 0.5% |
ALNYAlnylam Pharmaceuticals, Inc. | 2.3K | ±0% | $695.4K | 0.5% |
ASNDAscendis Pharma A/S | 2.6K | New | $685.5K | 0.5% |
PFEPfizer Inc | 27.5K | ±0% | $662.2K | 0.5% |
ARDXArdelyx, Inc. | 122.4K | ±0% | $624.2K | 0.4% |
PRVAPrivia Health Group, Inc. | 24.1K | −11.1% | $621K | 0.4% |
PTCTPTC Therapeutics, Inc. | 7.5K | +12.3% | $609.3K | 0.4% |
IONSIonis Pharmaceuticals Inc | 7.2K | ±0% | $570.9K | 0.4% |
AGMBAgomAb Therapeutics NV | 43.5K | ±0% | $564.6K | 0.4% |
BMRNBioMarin Pharmaceutical Inc | 9.5K | ±0% | $540.7K | 0.4% |
ONCBeOne Medicines Ltd. | 1.9K | ±0% | $532.9K | 0.4% |
HUMHumana Inc | 1.3K | New | $497.3K | 0.3% |
JAZZJazz Pharmaceuticals plc | 1.8K | ±0% | $421.7K | 0.3% |
RPRXRoyalty Pharma plc | 7.2K | ±0% | $403.7K | 0.3% |
BIIBBiogen Inc. | 1.9K | ±0% | $399.7K | 0.3% |
MLYSMineralys Therapeutics, Inc. | 14.6K | −53.9% | $393K | 0.3% |
ILMNIllumina, Inc. | 2.1K | ±0% | $374.9K | 0.3% |
AXSMAxsome Therapeutics, Inc. | 1.5K | ±0% | $367.2K | 0.3% |
SNDXSyndax Pharmaceuticals Inc | 15.7K | −50.5% | $342.8K | 0.2% |
RVMDRevolution Medicines, Inc. | 1.8K | ±0% | $342.7K | 0.2% |
ABVXAbivax S.A. | 2.3K | ±0% | $311.8K | 0.2% |
BBIOBridgeBio Pharma, Inc. | 4.1K | −49.4% | $305.4K | 0.2% |
MRNAModerna, Inc. | 4.4K | ±0% | $304.6K | 0.2% |
GHGuardant Health, Inc. | 2K | ±0% | $297.1K | 0.2% |
INCYIncyte Corp | 2.4K | ±0% | $266.4K | 0.2% |
ORICOric Pharmaceuticals, Inc. | 23.5K | ±0% | $254.5K | 0.2% |
SPRYARS Pharmaceuticals, Inc. | 29.9K | −62.2% | $239.5K | 0.2% |
GPCRStructure Therapeutics Inc. | 4.3K | −69.3% | $232.1K | 0.2% |
MEDPMedpace Holdings, Inc. | 430 | ±0% | $227.7K | 0.2% |
TEMTempus AI, Inc. | 3.9K | New | $224.8K | 0.2% |
CRBPCorbus Pharmaceuticals Holdings, Inc. | 20K | New | $187.6K | 0.1% |
PALIPalisade Bio, Inc. | 88K | ±0% | $183.9K | 0.1% |
ENGNenGene Therapeutics Inc. | 21.7K | New | $37.5K | 0.1% |
